Asgar Ali

1.5k total citations
43 papers, 1.2k citations indexed

About

Asgar Ali is a scholar working on Pharmaceutical Science, Analytical Chemistry and Molecular Biology. According to data from OpenAlex, Asgar Ali has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmaceutical Science, 11 papers in Analytical Chemistry and 7 papers in Molecular Biology. Recurrent topics in Asgar Ali's work include Advanced Drug Delivery Systems (14 papers), Advancements in Transdermal Drug Delivery (11 papers) and Analytical Methods in Pharmaceuticals (10 papers). Asgar Ali is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Advancements in Transdermal Drug Delivery (11 papers) and Analytical Methods in Pharmaceuticals (10 papers). Asgar Ali collaborates with scholars based in India, Saudi Arabia and Pakistan. Asgar Ali's co-authors include Javed Ali, Sanjula Baboota, Shrestha Sharma, Jasjeet Kaur Sahni, Mohd. Aqil, Yasmin Sultana, Syed Sarim Imam, Ameeduzzafar Zafar, Kanchan Kohli and Javed Ahmad and has published in prestigious journals such as Molecules, International Journal of Pharmaceutics and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Asgar Ali

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asgar Ali India 19 509 284 194 118 111 43 1.2k
Ajay Semalty India 22 633 1.2× 389 1.4× 188 1.0× 119 1.0× 121 1.1× 48 1.6k
Mona Semalty India 22 588 1.2× 375 1.3× 189 1.0× 114 1.0× 122 1.1× 46 1.5k
Hema Chaudhary India 13 409 0.8× 244 0.9× 156 0.8× 95 0.8× 93 0.8× 41 1.1k
Hatim S. AlKhatib Jordan 23 378 0.7× 291 1.0× 235 1.2× 230 1.9× 98 0.9× 75 1.4k
Ádley Antonini Neves de Lima Brazil 18 328 0.6× 241 0.8× 208 1.1× 133 1.1× 80 0.7× 56 1.1k
Ankit Awasthi India 26 294 0.6× 408 1.4× 195 1.0× 155 1.3× 118 1.1× 70 1.6k
Rubiya Khursheed India 28 407 0.8× 498 1.8× 257 1.3× 264 2.2× 133 1.2× 67 2.0k
Tejal Gandhi India 22 403 0.8× 370 1.3× 135 0.7× 90 0.8× 74 0.7× 111 1.6k
Priya Ranjan Prasad Verma India 20 547 1.1× 271 1.0× 138 0.7× 147 1.2× 40 0.4× 84 1.2k
Shrestha Sharma India 14 286 0.6× 337 1.2× 172 0.9× 129 1.1× 148 1.3× 33 1.2k

Countries citing papers authored by Asgar Ali

Since Specialization
Citations

This map shows the geographic impact of Asgar Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asgar Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asgar Ali more than expected).

Fields of papers citing papers by Asgar Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asgar Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asgar Ali. The network helps show where Asgar Ali may publish in the future.

Co-authorship network of co-authors of Asgar Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Asgar Ali. A scholar is included among the top collaborators of Asgar Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asgar Ali. Asgar Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Farooq, Uzma, Mohd. Aamir Mirza, Abdullah Alshetaili, et al.. (2024). In silico and in vitro assessment of an optimized QbD-guided myoinositol and metformin-loaded mucus-penetrating particle-based gel for the amelioration of PCOS. Nanoscale Advances. 6(2). 648–668. 5 indexed citations
4.
Gupta, Priya, Yub Raj Neupane, Bharti Mangla, et al.. (2023). Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer. Molecules. 28(5). 2343–2343. 22 indexed citations
5.
Ali, Asgar, Zeenat Iqbal, Mohd. Aamir Mirza, et al.. (2023). Natural Medicine a Promising Candidate in Combating Microbial Biofilm. Antibiotics. 12(2). 299–299. 30 indexed citations
6.
Hassan, Nazia, et al.. (2021). Investigating natural antibiofilm components: a new therapeutic perspective against candidal vulvovaginitis. Medical Hypotheses. 148. 110515–110515. 6 indexed citations
7.
8.
Ahmad, Iqbal, et al.. (2019). Improved cardioprotective effects of hesperidin solid lipid nanoparticles prepared by supercritical antisolvent technology. Colloids and Surfaces B Biointerfaces. 187. 110628–110628. 56 indexed citations
9.
Hassan, Nazia, Pooja Jain, Kalicharan Sharma, et al.. (2019). Molecular Docking-Guided Ungual Drug-Delivery Design for Amelioration of Onychomycosis. ACS Omega. 4(5). 9583–9592. 21 indexed citations
10.
Khan, Nazia, Ameeduzzafar Zafar, Asgar Ali, & Farhan Jalees Ahmad. (2018). A Novel Validated Stability-indicating HPTLC Method to Quantitate Forskolin as a Bulk Drug and in a Nanosuspension. Indian Journal of Pharmaceutical Sciences. 80(5). 2 indexed citations
11.
Aslam, Mohammed, Anam Khan, Syed Sarim Imam, et al.. (2014). Nanostructured lipid carriers of pioglitazone for transdermal application: from experimental design to bioactivity detail. Drug Delivery. 23(2). 601–609. 66 indexed citations
12.
Aqil, Mohd., Syed Sarim Imam, Abdul Ahad, Yasmin Sultana, & Asgar Ali. (2013). A validated RP-HPLC method for simultaneous determination of propranolol and valsartan in bulk drug and gel formulation. Journal of Pharmacy And Bioallied Sciences. 5(1). 61–61. 27 indexed citations
13.
Gupta, Himanshu, Mohd. Aqil, R. K. Khar, et al.. (2013). Nanoparticles ladenin situgel of levofloxacin for enhanced ocular retention. Drug Delivery. 20(7). 306–309. 29 indexed citations
14.
Sultana, Yasmin, et al.. (2011). Formulation and optimization of alkaline extracted ispaghula husk microparticles of isoniazid –in vitroandin vivoassessment. Journal of Microencapsulation. 28(6). 472–482. 17 indexed citations
15.
Ahad, Abdul, Mohd. Aqil, Kanchan Kohli, et al.. (2011). Interactions between Novel Terpenes and Main Components of Rat and Human Skin: Mechanistic View for Transdermal Delivery of Propranolol Hydrochloride. Current Drug Delivery. 8(2). 213–224. 62 indexed citations
16.
Sultana, Yasmin, et al.. (2011). Formulation and optimization of rifampicin microparticles by Box-Behnken statistical design. Pharmaceutical Development and Technology. 17(6). 687–696. 3 indexed citations
17.
Aqil, Mohd., Asgar Ali, Yasmin Sultana, & Nilanjan Saha. (2007). Comparative Bioavailability of Metoprolol Tartrate after Oral and Transdermal Administration in Healthy Male Volunteers. Clinical Drug Investigation. 27(12). 833–839. 8 indexed citations
18.
Aqil, Mohd., et al.. (2005). Transdermal Drug Delivery of Labetolol Hydrochloride: System Development, In Vitro; Ex Vivo and In Vivo Characterization. Current Drug Delivery. 2(2). 125–131. 17 indexed citations
19.
Rastogi, Rachna, Yasmin Sultana, Asgar Ali, & Mohd. Aqil. (2005). Particulate and Vesicular Drug Carriers in the Management of Tuberculosis. Current Drug Delivery. 3(1). 121–128. 12 indexed citations
20.
Charoo, Naseem A., Kanchan Kohli, Asgar Ali, & Areeg Anwer Ali. (2003). Ophthalmic Delivery of Ciprofloxacin Hydrochloride from Different Polymer Formulations: In Vitro and In Vivo Studies. Drug Development and Industrial Pharmacy. 29(2). 215–221. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026